We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Search
Filters
9068 Results

Congress Abstract

Low vs intermediate dose radiotherapy in head & neck MALT lymphoma with and without Sjogren syndrome
Authors: Shelley|, Charlotte(1)*[charlotteshelley@nhs.net];Brady|, Jessica(2);Rahman|, Fareen(2);Mikhaeel|, George(2);
(1)Guys and St. Thomas's NHS Trust, Oncology, Nr. Reading, United Kingdom;(2)Guys and St. Thomas's NHS Trust, Oncology, London, United Kingdom;
Show Affiliations
2020
Poster
ESTRO 2020

Congress Abstract

PROMs versus clinician scored toxicity. Do we need both?
Authors: GILBERT|, ALEXANDRA(1,2)*[alexandragilbert@doctors.org.uk];
(1)LEEDS CANCER CENTRE, CLINICAL ONCOLOGY, LEEDS, UNITED KINGDOM;(2)UNIVERSITY OF LEEDS, MEDICINE, LEEDS, UNITED KINGDOM;
Show Affiliations
2020
ESTRO 2020

Congress Abstract

Interfractional changes of rectum and bladder effect on uterus position in cervix external beam RT
Authors:

Yat Man Tsang1, Esther Sulaili1, Adele Steward-lord2, Daniel Megias1, Hannah Tharmalingam3, Peter Hoskin3

1Mount Vernon Cancer Centre, Radiotherapy, Northwood, United Kingdom; 2London South Bank University, Institute of Health and Social Care, London, United Kingdom; 3Mount Vernon Cancer Centre, Clinical Oncology, Northwood, United Kingdom

Show Affiliations
2021
Oral
ESTRO 2021

Journal Article

Photons, protons or carbon ions for stage I non-small cell lung cancer – Results of the multicentric ROCOCO in silico study
Authors: Krista C.J. Wink, Erik Roelofs, Charles B. Simone, David Dechambre, Alina Santiago, Judith van der Stoep, Wim Dries, Julia Smits, Stephen Avery, Filippo Ammazzalorso, Nicolas Jansen, Urszula Jelen, Timothy Solberg, Dirk de Ruysscher, Esther G.C. Troost
2018
Radiotherapy and Oncology

Congress Abstract

Consistency in high dose CTV generation using geometric margins for radiotherapy in HNSCC patients
Authors:

Ruta Zukauskaite1,4, Jesper Grau Eriksen2,3, Elo Andersen5, Jørgen Johansen1, Eva Samsøe5,6, Simon Long Krogh7, Jens Overgaard8, Cai Grau9,9, Christian Rønn Hansen9,10,7

1Odense University Hospital, Department of Oncology, Odense , Denmark; 2Aarhus University Hospital, Department of Oncology, Aarhus, Denmark; 3Aarhus University Hospital, Department of Experimental Clinical Oncology, Aarhus, Denmark; 4University of Southern Denmark, Department of Clinical Research, Odense , Denmark; 5Copenhagen University Hospital Herlev, Department of Oncology, Copenhagen, Denmark; 6Zealand University Hospital, Naestved, Department of Oncology, Copenhagen, Denmark; 7Odense University Hospital, Laboratory of Radiation Physics, Odense, Denmark; 8Aarhus University Hosputal, Department of Experimental Clinical Oncology, , Aarhus, Denmark; 9Aarhus University Hospital, Department of Experimental Clinical Oncology, , Aarhus, Denmark; 10University of Southern Denmark, Department of Clinical Research, Odense, Denmark

Show Affiliations
2022
Oral presentation
ICHNO–ECHNO 2022

Congress Abstract

A quantitative evaluation of deformable image registration based on Halcyon MVCBCT images
Authors: Huang|, Yuliang(1);Wu|, Hao(1);Wang|, Weihu(1);Zhang|, Yibao(1)*[ybzhang77@gmail.com];
(1)Key Laboratory of Carcinogenesis and Translational Research Ministry of Education/Beijing- Department of Radiation Oncology- Peking University Cancer Hospital & Institute, Department of Radiotherapy, Beijing, China;
Show Affiliations
2020
Poster
ESTRO 2020

Congress Abstract

Report dose-to-medium in clinical trials; a consensus from the Global Harmonisation Group
Authors:

Stephen Kry1, Jessica Lye2, Catharine Clark3, Nicolaus Andratschke4, Alexis Dimitriadis5, David Followill1, Rebecca Howell6, Mohammad Hussein7, Masayori Ishikawa8, Satoshi Kito9, Tomas Kron10, Jonny Lee11, Jeff Michalski12, Angelo Monti13, Nick Reynaert14, Paige Taylor1, Karen Venables15, Ying Xiao16, Joerg Lehmann17

1Imaging and Radiation Oncology Core / MD Anderson Cancer Center, Radiation Physics, Houston, USA; 2 Australian Clinical Dosimetry Service, Australian Radiation Protection and Nuclear Safety Agency; Olivia Newton-John Cancer Research and Wellness Centre, Radiation physics, Melbourne, Australia; 3NIHR Radiotherapy Trials Quality Assurance Group; University College London Hospital; University College London; National Physical Laboratory, Radiation Physics, London, United Kingdom; 4European Organisation for Research and Treatment of Cancer Radiotherapy Quality Assurance Group; University Hospital of Zurich, University of Zurich, Radiation Oncology, Zurich, Switzerland; 5International Atomic Energy Agency, Dosimetry and Medical Radiation Physics Section, Vienna, Austria; 6Radiation Dosimetry Services / MD Anderson Cancer Center, Radiation Physics, Houston, USA; 7National Physical Laboratory, Physics, Teddington, United Kingdom; 8Japan Clinical Oncology Group / Hokkaido University, Faculty of Health Sciences, Hokkaido, Japan; 9Japan Clinical Oncology Group / Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Radiation Oncology, Tokyo, Japan; 10Trans Tasman Radiation Oncology Group (TROG) / Peter MacCallum Cancer Centre, Radiation Oncology, Melbourne, Australia; 11NIHR Radiotherapy Trials Quality Assurance Group / Mount Vernon Cancer Centre, Radiation Oncology, Northwood, United Kingdom; 12Imaging and Radiation Oncology Core / Washington University School of Medicine, Radiation Oncology, St. Louis, USA; 13European Organisation for Research and Treatment of Cancer (EORTC) / ASST GOM Niguarda Hospital, Medical Physics, Milan, Italy; 14European Organisation for Research and Treatment of Cancer / Jules Bordet Institute, Université Libre de Bruxelles, Medical physics, Brussels, Belgium; 15NIHR Radiotherapy Trials Quality Assurance Group / Mount Vernon Cancer Centre, Radiation oncology, Northwood, United Kingdom; 16Imaging and Radiation Oncology Core / University of Pennsylvania, Radiation Oncology, Philadelphia, USA; 17Trans Tasman Radiation Oncology Group (TROG) / Calvary Mater Newcastle, Radiation Oncology, Newcastle, Australia

Show Affiliations
2021
Poster Discussion
ESTRO 2021

Journal Article

Space-making particle therapy for sarcomas derived from the abdominopelvic region
Authors: Shohei Komatsu, Yusuke Demizu, Nor Shazrina Sulaiman, Kazuki Terashima, Masaki Suga, Masahiro Kido, Hirochika Toyama, Sunao Tokumaru, Tomoaki Okimoto, Ryohei Sasaki, Takumi Fukumoto
2020
Radiotherapy and Oncology

Congress Abstract

How to crunch the numbers \r
Authors: Blanchard|, Pierre(1)*[Pierre.BLANCHARD@gustaveroussy.fr];
(1)Institut Gustave Roussy, Radiation Oncology, Villejuif, France;
Show Affiliations
2020
ESTRO 2020

Congress Abstract

Peritreatment peripheral blood cells predict progression hazard in esophageal cancer after treatment
Authors: CHEN|, Jianzhou(1,2)*[jianzhou.chen@oncology.ox.ac.uk];Xu|, Liangyu(1,3);Guo|, Hong(1);Huang|, Ruihong(1);Guo|, Longjia(1);Yu|, Yuanxiang(1);Wu|, Fangcai(1);Chen|, Zhijian(1,4);Li|, Derui(1);Chen|, Chuangzhen(1);
(1)Cancer Hospital of Shantou University Medical College, Radiation Oncology, Shantou, China;(2)University of Oxford, Oncology, Oxford, United Kingdom;(3)Tungwah Hospital of Sun Yat-Sen University, Radiation Oncology, Dongguan, China;(4)Cancer Hospital-Chinese Academy of Medical Sciences, Radiation Oncology, Shenzhen, China;
Show Affiliations
2020
Poster
ESTRO 2020
*:*